Part Details | BERACTANT INTRATRACHEAL SUSPENSION
6505-01-372-0173
Alternate Parts: NDC00074104008, NDC00074-1040-08, SURVANTA, F93A339, SURVANTA, NDC00074104008, NDC00074-1040-08, 6505-01-372-0173, 01-372-0173, 6505013720173, 013720173
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | FEB 28, 1993 | 01-372-0173 | 49780 ( BERACTANT INTRATRACHEAL SUSPENSION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-372-0173
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00074-1040-08 | 23281 | ABBOTT LABORATORIES INCROSS PRODUCTS DIV |
| SURVANTA | 23281 | ABBOTT LABORATORIES INCROSS PRODUCTS DIV |
| F93A339 | 66735 | AIR FORCE MEDICAL LOGISTICS OFFICE |
| SURVANTA | 17550 | ROSS LABORATORIES, INC. |
| NDC00074-1040-08 | 17550 | ROSS LABORATORIES, INC. |
Technical Data | NSN 6505-01-372-0173
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY25.000 MILLIGRAMS PHOSPHOLIPIDS |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 8.000 MILLILITERS |
| FEATURES PROVIDED | STERILE |
| SPECIAL FEATURES | USED FOR PREVENTION AND TREATMENT OF RDS(HYALINE MEMBRANE DISEASE)IN PREMATURE INFANTS;NOTE:G;NOT FOR INJECTION |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BERACTANT INTRATRACHEAL SUSPENSION 8ML VIAL |